标题 |
[求助补充材料] Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
|
网址 | |
DOI |
10.1016/s0140-6736(24)00101-6
doi
|
其它 |
期刊:The Lancet 作者:Alexa B. Kimball; Gregor B. E. Jemec; Christopher Sayed; Joslyn S. Kirby; Errol P. Prens; et al 出版日期:2024-05-22 |
求助人 | |
下载 |